Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-21

Clinical Trial Update: The Effect of Paricalcitol on Creatinine Filtration, Secretion and Glomerular Filtration Rate [Phase 4]

View source ↗

Summary

Phase 4 trial assessing paricalcitol's effect on creatinine filtration, secretion, and glomerular filtration rate in chronic kidney disease; results have been p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Paricalcitol (paricalcitol)

Snippet

Sponsor: Indiana University | Conditions: Chronic Kidney Disease | Phase 4 | Status: COMPLETED | Results posted: 2013-05-21